MedTrace Logo

Lung Function in Patients With Early Type 2 Diabetes Mellitus

NCT03167918 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-05-30

No results posted yet for this study

Summary

To investigate the protective effect of calcium dobesilate, Xuefuzhuyu Decoction, calcium dobesilate combined with Xuefuzhuyu Decoction on the early lung function of type 2 diabetes mellitus

Conditions

Interventions

DRUG

Calcium Dobesilate

gave each patient 0.5 g bid，

DRUG

Xuefuzhuyu Decoction

gave each patient100 ml bid，po

DRUG

Xuefuzhuyu Decoction & Calcium dobesilate

gave each patient Calcium dobesilate 0.5 g bid，po and Xuefuzhuyu Decoction 100 ml bid，po

DRUG

metformin

gave each patient 1000 mg, bid, PO

DRUG

Mecobalamin Tablets

gave each patient 0.5 mg bid, PO

Sponsors & Collaborators

  • Liaoning University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Xiao-lin Jiang · Liaoning University of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-21
Primary Completion
2017-04-01
Completion
2017-05-01

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03167918 on ClinicalTrials.gov